Kyle Chan is listed as a director on 4 SEC Form D filings by 1 issuer between Dec 2009 and Mar 2014: TheraVasc Inc. (Cleveland, OH — pharmaceuticals — 2009–2014; $1.84M reported sold to 20 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Anthony Giordano (4 shared filings), John Zak (4 shared filings), John Huston (2 shared filings), Susan Luria (2 shared filings), Stewart William (1 shared filing) and 1 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Kyle. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 1 bankruptcy case matching the name listed in Key records below.
What this means 1 record came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 4 public filings for Kyle Chan and found 8 differences, 4 worth asking the sponsor about: Bankruptcy case: Kyle P. Chan; 31% of the money raised went to insiders; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.